Invention Grant
- Patent Title: Urea derivative or pharmacologically acceptable salt thereof
-
Application No.: US16011050Application Date: 2018-06-18
-
Publication No.: US10252992B2Publication Date: 2019-04-09
- Inventor: Hiroyasu Takahashi , Yoshifumi Saito , Kosuke Tsuda , Mitsuhito Shibasaki , Kohei Ohata
- Applicant: Kyorin Pharmaceutical Co. Ltd.
- Applicant Address: JP Tokyo
- Assignee: Kyorin Pharmaceutical Co., Ltd.
- Current Assignee: Kyorin Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Baker & Hostetler LLP
- Priority: JP2013-245502 20131128
- Main IPC: A61K31/4015
- IPC: A61K31/4015 ; C07D207/12 ; C07D207/273 ; C07D403/12 ; C07D401/04 ; C07D401/12 ; C07D405/04 ; C07D405/12 ; C07D409/04 ; C07D409/12 ; C07D413/12 ; C07D417/12 ; C07D209/54 ; C07D405/14 ; C07D413/14 ; C07D401/06 ; C07D403/04 ; C07D409/14 ; C07D413/06 ; C07D207/22
Abstract:
Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect.The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.
Public/Granted literature
- US20180290974A1 Urea Derivative Or Pharmacologically Acceptable Salt Thereof Public/Granted day:2018-10-11
Information query
IPC分类:
